Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Change in Taxes (2018 - 2024)

Inmune Bio's Change in Taxes history spans 6 years, with the latest figure at $20000.0 for Q1 2024.

  • For Q1 2024, Change in Taxes fell 41.18% year-over-year to $20000.0; the TTM value through Mar 2024 reached $1.9 million, down 31.12%, while the annual FY2023 figure was $175000.0, 176.42% up from the prior year.
  • Change in Taxes for Q1 2024 was $20000.0 at Inmune Bio, down from $34000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $1.9 million in Q3 2021 and bottomed at -$45000.0 in Q4 2021.
  • The 4-year median for Change in Taxes is $276500.0 (2020), against an average of $439900.0.
  • The largest annual shift saw Change in Taxes skyrocketed 972.8% in 2020 before it plummeted 120.36% in 2021.
  • A 4-year view of Change in Taxes shows it stood at $221000.0 in 2020, then tumbled by 120.36% to -$45000.0 in 2021, then skyrocketed by 175.56% to $34000.0 in 2023, then tumbled by 41.18% to $20000.0 in 2024.
  • Per Business Quant, the three most recent readings for INMB's Change in Taxes are $20000.0 (Q1 2024), $34000.0 (Q1 2023), and -$45000.0 (Q4 2021).